News on Medial

Peak XV closes $1.3 Bn fund for India and APAC

EntrackrEntrackr · 6h ago
Peak XV closes $1.3 Bn fund for India and APAC
Medial

Peak XV Partners on Friday announced the closing of $1.3 billion in fresh capital commitments across its India Seed, India Venture, and Asia Pacific funds. This is the firm’s first fundraise since its separation from Sequoia Capital. In a post on X, Peak XV Partners said the new capital, along with uninvested capital from its existing growth fund, will strengthen its ability to back founders building category-defining companies across multiple stages. The firm said it continues to focus on supporting outlier founders, a strategy it has followed for over two decades. The announcement comes as Peak XV sees increasing opportunities driven by artificial intelligence across India and the broader Asia Pacific region. The firm said that while early AI breakthroughs were concentrated in Silicon Valley, the opportunity set has expanded, supported by improving market depth, talent quality, and global ambition among startups in the region. In an interview with ET, Peak XV Partners managing director Shailendra Singh said the firm will continue to invest across seed, venture, and growth stages, writing cheques ranging from single-digit million dollars to $100 million, while sharpening its cross-border strategy to build an India-APAC corridor. The latest fundraise follows Peak XV’s 2022 announcement of $2.85 billion in growth and venture capital commitments for India and Southeast Asia, with $2 billion allocated to India. The firm later reduced the fund size by 16 percent in 2024, citing elevated public market valuations in India. The fundraise also comes at a time when several Peak XV portfolio companies are seeing public market momentum. Meesho, Groww, and Pine Labs have listed, while Zetwerk, Curefoods, and Infra.Market are preparing for initial public offerings. Since its split from Sequoia Capital, Peak XV has backed startups including Scapia, RapidCanvas, Sarvagram, Atlys, Mokobara, Stable Money, GoodScore, and Sarvam AI.

Related News

Ixigo closes Rs 176 Cr pre-IPO secondary placement

EntrackrEntrackr · 1y ago
Ixigo closes Rs 176 Cr pre-IPO secondary placement
Medial

Le Travenues Technology Limited, which operates travel booking platform Ixigo, is all set to make its debut on stock exchanges on 10th June with the price band of Rs 88-93 per share. The firm announced its pre-IPO secondary placement of Rs 176.2 crore ($21 million) at the top-end price (Rs 93) a day before Anchor Book. The early backer SAIF Partners sold its 1,07,52,689 shares worth Rs 100 crore ($12 million) to Ashoka India (White Oak), Tata Digital Fund, and Bay Capital. On the other hand, PeakXV sold its 6,989,248 shares worth Rs 65 crore ($7.8 million) to Bay Capital and Steadview Holding. Micromax and Madison India also sold their 12,05,268 shares to Steadview Capital worth Rs 11.2 crore ($1.3 million) in a pre-IPO secondary round. According to the company, SAIF partners will hold 20.52% after this secondary transaction while Peak XV and Micromax will own 13.81% and 5.52% respectively. Ixigo’s co-founders Aloke Bajpai, and Rajnish Kumar cumulatively hold 16.65% of the company. As per the analysis, SAIF Partners and Peak XV will get a hefty 13X and 8.2X returns from Ixigo respectively. Micromax Limited will also enjoy a good 10.88X return from the Gurugram-based company. Ixigo’s public offering will be open from 10th June to June 12 with a minimum lot size of 161 for the retail investor. For the small non-institutional investors, the minimum lot size is 14 lots. Ixigo demonstrated decent growth during the first nine months of the last fiscal year (FY24). Its operating revenue stood at Rs 491 crore while the firm also made a sizable profit of Rs 65.7 crore in the same period.

ChrysCapital closes $2.2 Bn Fund X

EntrackrEntrackr · 3m ago
ChrysCapital closes $2.2 Bn Fund X
Medial

ChrysCapital has closed Fund X at $2.2 billion, the largest private equity fund raised by an India-focused firm. Fund X is a 60% increase from Fund IX of $1.35 billion, closed in 2022. The firm plans to invest the capital in established companies across consumer, healthcare, financial services, enterprise technology, and industrial sectors. ChrysCapital has now raised around $8.5 billion across ten private equity funds, a continuation vehicle, and a public markets fund since 1999. It has deployed over $5.5 billion across 110 portfolio companies and realised $7.8 billion across 80 exits with a reported 3.0x ROI. Its past investments include Intas Pharmaceuticals, Mankind Pharma, GeBBS Healthcare, Infogain, NSE, and Awfis. Fund X added over 30 new global investors, including pension funds, insurers, asset managers, and family offices from Japan, the Middle East, Southeast Asia, Europe, and the US. For the first time, ChrysCapital also raised capital from Indian institutional investors and large family offices. The fund reached its final close within six months of its first close. The firm plans to deploy Fund X over the next 3–4 years and has several transactions in progress. The strategy continues to focus on majority and minority investments in businesses with strong governance, clear growth levers, and defined exit visibility. ChrysCapital competes with PE firms active in India such as TPG, Bain Capital, KKR, Blackstone, Carlyle, Warburg Pincus, and Multiples.

Download the medial app to read full posts, comements and news.